Myopia is experiencing an epidemic rise across the world, most dramatically among younger people (college educated and high school graduates) in East and South Asia where the prevalence has reached almost 100 percent in some demographics.
ODs have a responsibility to be in a guidance role with patients and families in order to raise awareness of the concerns involved in social media—including the “addiction” to such devices.
Historically ODs have had few options for patients. With a new topical eye drop on the market, optometrists are able to target the underlying concern behind neurotrophic corneal defects: the damaged corneal nerves themselves. In the latest Defocus Media podcast, Michael Marino, OD, shares his experience as the first optometrist to prescribe Oxervate in North Carolina.
This expert clinical resource from Optometry Times reviews the 2020 drug pipeline, discusses dry eye management following cataract and refractive surgeries, examines recent updates to treatment for Sjögren’s syndrome, and more.
Get the latest on dry eye now.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: MultiMedia Healthcare
535 Connecticut Avenue, Suite 300
Norwalk, CT, 06854, USA
Get the latest on dry eye now.
